Sign in
8-K/A

Current Report

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001213900-26-042017

Executive or director change · Bylaws or fiscal year change · Other events

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading ea0285032-8ka425_apimeds.htm…